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Abstract 
 
Influenza A virus is the most relevant clinical pathogen of 
the orthomoyxoviridae family for humans. It is known to 
predispose the lung to secondary bacterial infections which 
lead to bacterial pneumonia. Usually infection with influenza 
virus causes an increase in bacterial load, however, 
coinfection of mice with influenza and Legionella 
pneumophila leads to immunopathology without an increase 
in pathogen burden. Investigating possible mechanisms for 
this immunopathology was our main interest. TNFα known 
to cause immunopathology, was elevated after the bacterial 
infection. We therefore wanted to look at the effect of TNFα 
on influenza infected lung epithelial cells. The results 
showed us a clear synergism suggesting an important role 
of TNFα during coinfections. Zinc, known to be a 
cytoprotectant and anti-apoptotic agent, was used to 
investigate a possible impact on the cell survival during 
infection with influenza virus combined with TNFα. A rescue 
of the synergistic effect could not be seen in our results. 
Another possibility for the increase in immunopathology is 
an inefficient uptake of dead cells by infected macrophages, 
which would lead to an increased release of pro-
inflammatory cytokines. Therefore, infected macrophages 
and uninfected macrophages were compared for their ability 
to phagocytose influenza A virus infected or apoptotic cells. 
These results suggest strongly that macrophages are 
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directly affected by influenza A virus infection in vitro. In 
addition, observation of macrophages by live imaging 
revealed an altered motility upon infection with influenza 
virus.  
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Zusammenfassung 
 
Influenza A Virus ist das für den Menschen relevanteste 
klinische Pathogen der orthomyxoviridea Familie. Es ist 
bekannt dafür die Lungen anfälliger für sekundäre 
Bakterielle Infektionen zu machen, die bakterielle 
Lungenentzündungen auslösen. Während einer Coinfektion 
mit Influenza steigt normalerweise die Anzahl an Bakterien. 
Dies ist jedoch nicht der Fall bei einer Coinfektion von 
Influenza mit Legionella pneumophila. Hierbei kommt es zu 
einer Immunpathologie, ohne einen Anstieg der bakteriellen 
Belastung. Unsere Untersuchungen umfassen 
unterschiedlicher Mechanismen, die zu dieser 
Immunpathologie führen könnten. TNFα, bekannt dafür 
Immunpathologie auszulösen, ist nach der bakteriellen 
Infektion erhöht. Aus diesem Grund wollten wir in Erfahrung 
bringen, was für einen Effekt TNFα auf Influenza infizierte 
Zellen hat. Die Ergebnisse zeigen uns einen klaren 
Synergismus, der eine wichtige Rolle von TNFα während 
Coinfektionen nahe legt. Zink, bekannt für seine 
Zellschützende und anti-apoptotische Funktion, wurde 
verwendet, um eine mögliche Rolle für das Überleben der 
Zellen während einer Influenza Infektion zusammen mit 
TNFα zu analysieren. Unsere Ergebnisse konnten keine 
Reduktion des Synergismus aufzeigen. Eine weitere 
Möglichkeit der erhöhten Immunpathology ist die 
unzureichende Aufnahme von toten Zellen durch infizierte 
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Makrophagen, welche eine erhöhte Freisetzung von pro-
inflammatorischen Zytokinen zur Folge hätte. Aus diesem 
Grund wurden infizierte und uninfizierte Makrophagen in 
ihrer Fähigkeit verglichen, Influenza infizierte oder tote 
Zellen zu phagozytieren. Die Ergebnisse legen nahe, das 
eine Influenza A Virus Infektion in vitro einen direkten 
Einfluß auf Makrophagen hat. Weiters konnte während der 
Observation von Makrophagen bei Lebendzellbeobachtungs-
Experimenten, ein veränderter Bewegungsablauf durch eine 
Infektion mit Influenza beobachtet werden.  
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1 Introduction 
 
1.1 Influenza 
 
Influenza A Virus (IAV) is a negative sense, single stranded 
RNA virus of the orthomoyxoviridae family. The RNA 
consists of 8 segments encoding 11 proteins (1) (Figure 1). 
Influenza is known to cause respiratory diseases by mainly 
infecting respiratory epithelial cells from where on the 
infection can spread to alveolar macrophages (2). 
 
 
The infectious route of the virus is through binding of 
the viral surface protein hemagglutinin (HA) to sialic acid 
sugars on their target cells (1-3). It is then taken up in an 
endosome from where the virus is able to release its viral  
Figure 1: Structure of an IAV showing its various proteins. Image copyright by 
Dr. Markus Eickmann, Institute for Virology, Marburg, Germany  
Source: http://www.influenzareport.com/ir/virol.htm 
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Figure 2: Shows the route of infection from an influenza Virus in an epithelial 
cell. Virus binds with hemagglutinin (HA) to the cell and gets taken up [1]. 
Release of the viral RNA and RNA polymerase into the cytoplasma from where it 
gets transported into the nucleus [2]. Transcription/replication of the RNA in the 
nucleus [3a/3b]. Translation of the mRNA in the cytoplasma [4]. Secretion of HA 
and neuroaminidase (NA) via Golgi apparatus to the cell surface [5b]. Viral 
proteins get transported back i
and core proteins leave nucleus and enter a formed bulge [6]. The virus buds off 
from the cell with the help of neuroaminidase which cuts the sialic acid sugars 
on the cell surface [7].
Source: 
http://www.ncbi.nlm.nih.gov/genomes/GenomesHome.cgi?taxid=10239&hopt=scheme
 
RNA, accessory proteins and RN
cytoplasm (4; 5)
transported into the nucleus where the transcription and 
replication of the RNA takes place
mRNA is transported to the ribosomes in the cytoplasm. 
Once the proteins are translated they either get secreted via 
the Golgi apparatus to the cell surface (HA, n
 
nto the nucleus to bind viral RNA [5a]. Viral RNA 
 
A polymerase into the 
. A complex is formed which then is 
 (6). The transcribed 
euroaminidase 
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(NA) and M2) or transported back into the nucleus to bind 
the replicated viral RNA (7). The newly replicated negative 
stranded RNA, RNA polymerase and other viral proteins 
leave the nucleus to enter a bulge in the cell that has been 
created by a cluster of HA, NA and M2 molecules to form a 
new virus particle. This is budded off from the cell by cutting 
the sialic acid sugars with the NA (3; 8) (Figure 2). After 
influenza has kept the cell alive long enough to propagate 
enough new viruses, it induces an apoptotic cell death of the 
infected cell (9-11). 
 
1.2 Immune response to influenza 
A very strong inflammatory response accompanies a normal 
influenza infection (12). The first step of the innate immune 
response is the destruction of infected cells by natural killer 
(NK) cells and the production of cytokines including IFN-α/β 
(13; 14). Type I IFNs are released by infected epithelial cells 
and macrophages, functioning to directly induce an antiviral 
state. Further they enhance the host immune response by 
upregulation of the gene expression of pro-inflammatory 
cytokines and MHC-class I complexes (15). The pro-
inflammatory cytokines (TNFα, IL-1β, IL-6) and chemokines 
(MCP-1, RANTES, MIP-1α/β, IP-10, IL-8 (in humans only)) 
(16; 17; 13) favour the extravasation of blood monocytes 
and the further development of antiviral and Th1-type 
immune response (13). For further protection against 
infection, B-cells produce antibodies against the cell surface 
HA and NA to neutralize free viruses by inhibiting the 
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established infections 
work as the main cell
already infected cells
 
Figure 3: Innate and adaptive immune responses against viruses.
Source: Abul K. Abbas, Cellular and molecular immunology, fifth edition; 2005
 
1.3 Coinfections
As recent studies have shown, the high mortality rate of 
some of the great pandemics of history 
can possibly be linked to a secondary bacterial infection, 
causing bacterial pneumonia 
mechanisms for the
bacterial infections
of NK cell activity by the influenza 
example, resulting in an impaired NK cell response to 
subsequent Staphylococcus aureus
 
 (18). To eradicate already 
CD8+ cytotoxic T-cells (CTL) cells 
ular source, that seek and destroy 
 (14) (Figure 3). 
 
 
like the Spanish flu 
(19; 20). There are many 
 influenza virus to predispose the lung to 
. One of the mechanisms is the inhibition 
virus infection (21)
 infection (22).  
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Another very important mechanism is increased 
adherence of bacteria to the host cell (23; 24). In the case 
of Streptococcus pneumoniae this is achieved by the 
influenza NA, which cuts off the sialic acid, leaving more 
space for bacterial binding sites (25). The result is a higher 
bacterial titer and an increased death in mouse models of 
coinfection (26; 27). For Streptococcus pyogenes it has 
been reported that the HA, which is expressed on the cell 
surface of influenza infected cells, promotes internalization 
of the bacteria. This leads to high death rate of the 
coinfected mice (28). 
An overreaction of the host immune response with an 
excessive cytokine production that results in 
immunopathology (29; 30) but no increase in bacterial 
burden can be seen in coinfected mice with Legionella 
pneumophila. The increase in the local inflammatory 
response includes the pro-inflammatory cytokines IL-6, IL-
1β and TNFα. Also a clear increase in damage to the lung 
epithelium is present when looking at lung sections (31) 
(Figure 4). We therefore became interested in studying this 
phenomenon. 
 1. Introduction 
Figure 4: Lung sections were stained by H&E and scored to look at epithelium 
damage.  
Source: Amanda M. Jamieson, R. J. H. a. R. M., 
influenza virus and Legionella pneumophila results in rapid lethal infectious 
pneumonitis. 2009. (unpublished manuscript)
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2 Aims 
 
We wanted to examine the reason for the immunopathology 
induced by L. pneumophila after a primary influenza 
infection. TNFα, elevated after the bacterial infection and 
known to cause immunopathology, became our main 
interest. Therefore we looked at the effect TNFα has on 
influenza infected lung epithelial cells. Zinc, known to be a 
cytoprotectant and anti-apoptotic agent (32; 33), was 
further used to try and counteract the increased cell death 
that we were able to see. Looking for the cause of elevated 
numbers of pro-inflammatory cytokines, macrophages were 
examined. Their ability to phagocytose apoptotic and 
infected cells is extremely important (34). A possible defect 
in the phagocytic ability of macrophages during an influenza 
virus infection would lead to an increased number of dead 
cells that turn secondary necrotic (35). The outcome is an 
increased pro-inflammatory release of these cells and might 
be the cause of the immunopathology that we see. To find 
other impacts of the viral infection on the functionality of 
macrophages, we observed their movement behaviour by 
live imaging.   
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3 Project 1 – Influenza and TNFα  
 
3.1 Introduction 
During a coinfection with L. pneumophila, TNFα is one of the 
pro-inflammatory cytokines that is increased (31). The main 
pathways activated by TNFα are NFκB, JNK, p38-MAPK and 
induction of cell death (36; 37) (Figure 5). 
The possibilities of cross-talk between the different 
pathways and the capability of inducing necrotic or apoptotic 
cell death, leading to extensive tissue damage, focused our 
interest on TNFα. We did experiments in vitro with cell lines 
and primary lung epithelial cells, using TNFα to mimic the 
secondary bacterial infection of L. pneumophila. We 
observed cell death induced by addition of TNFα before, at 
the same time and after Influenza A Virus (IAV) infection. 
What we saw is that IAV leads to an increased cell death 
after a subsequent TNFα addition. 
We examined a possible role for zinc in the increased 
cell death seen in coinfected epithelial cells. It is a well 
known cytoprotectant and anti apoptotic agent (32; 33) 
though too high concentrations may lead to cytoxicity (39). 
During normal bacterial infections a reduction in zinc levels 
correlates with optimal immune reaction and reduced 
virulence by the bacterial pathogen (40). However, 
prolonged reduction in zinc is also associated with a reduced 
immune function by impaired cytokine production, 
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predisposition to apoptosis (41) and a decreased T-cell (40) 
and B-cell function (42). 
 
 
Figure 5: TNFα and its different inducable pathways leading either to 
antiapoptotic gene expression or to induction of cell death. (38) 
Source: Rahman MM, McFadden G. Modulation of Tumor Necrosis Factor by Microbial 
Pathogens. PLoS Pathog 2006 Feb;2[2] 
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Concerning influenza, zinc has a direct inhibitory 
impact on the viral triggered apoptotic pathways (43; 44). 
Given that zinc can reduce influenza virus pathology, a 
reduction of the zinc levels after a bacterial infection might 
again increase its pathology due to a loss of the inhibitory 
functions of zinc (41). Pre-treatment, depletion and 
simultaneous addition of zinc to IAV infected and TNFα 
treated cells showed us indeed a higher cell death by 
depletion of zinc in single treated IAV cells. No rescue of cell 
death in cotreated cells could be seen. 
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3.2 Results 
3.2.1 Cytotoxicity of Influenza and TNFα in cell lines 
 
Our focus lay on the analysis of the cell death that is 
induced in cells having an IAV infection and the subsequent 
reaction of these infected cells to the pro-inflammatory 
cytokine TNFα. The experiments were done with the human 
A549 lung epithelial cell line and the mouse LL/2, MLE12, 
MLE15 cell lines. This was done to have a broad overview of 
this effect and to be able to compare the differences that 
might occur, especially between mouse and human. Due to 
differences in growth speed of the cell lines, the cell amount 
for the start of the experiment was determined to have 
10.000 cells for A549, MLE12 and MLE15 per well, while the 
LL/2 received 5.000 cells per well (data not shown). 
The first experiment of interest was to see the effect 
that different doses of TNFα would have on virus infected 
cells. LDH-Assay (45) revealed that TNFα addition increases 
the percentage of dead cells during an infection. A titration 
of TNFα led to a continuously lower cell death percentage in 
mouse cell lines (Figure 6) as well as in the human cell line. 
(Figure 7) An additional PI staining was done in parallel to 
the LDH-Assay for the LL/2 cell line that gave a similar 
result (Figure 8). 
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Figure 6: Mouse cell lines LL/2, MLE12 and MLE15 induced with different doses 
of TNFα, 5 hours after the virus infection. Experiments were analyzed with an 
LDH-Assay. Data is representative of two independent experiments with three 
replicates in each group. 
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Figure 7: Human cell line A549 induced with different doses of TNFα, 5 hours 
after the virus infection. Experiments were analyzed with an LDH-Assay. Data is 
representative of two independent experiments with three replicates in each 
group. 
 
Figure 8: Mouse cell line LL/2 induced with different doses of TNFα, 5 hours 
after the virus infection. Experiments were analyzed with PI staining. Data is 
from one experiment with one sample in each group. 
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If we focus now on the difference that we see between 
the highest amount of TNFα alone, the highest infection with 
IAV alone and the co treatment, the outcome is striking. All 
four cell lines have a synergistic increase in cell death by 
cotreatment with IAV and TNFα addition after 5 hours 
(Figure 9). Looking at the TNFα induction alone we are able 
to see that all four cell lines react differently, having only 
10% cell death with our human cell line A549. The mouse 
LL/2 cells in contrast had a high cell death of 40% with the 
highest amount of TNFα. IAV infection alone shows 
differences as well. The human cell line being more robust 
against the TNFα, also needs a higher amount of IAV to see 
cell death during the infection. Both differences are very 
likely due to the use of mouse TNFα and mouse adapted 
influenza A virus for all cell lines. No increase in cell death 
above the normal TNFα cell death level can be observed in 
the LL/2 with the lower IAV infection. This indicates that it is 
below an effective virus infection (Figure 6). 
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Figure 9: Comparing the effect of the highest induced TNFα alone, the highest 
infection with IAV alone and the co treated cells which had TNFα added 5h after 
the IAV infection. A synergistic effect in the co treated cells can be seen with an 
immense increase of the percentage in cell death. Data is representative of two 
independent experiments with three replicates in each group. 
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3.2.2 Different timepoints of TNFα addition 
 
The synergistic effect was seen at the given time point after 
adding TNFα 5h after the infection. We then wanted to know 
if the addition of TNFα 5h before or at the same time as the 
virus infection would lead to a different outcome. First we 
analyzed the ability of LL/2 and A549 if they were able to 
express TNFα themselves, which would nullify the relevance 
of adding TNFα at different time points. Previous studies 
have suggested that mouse bronchoalveolar epithelial cells 
do express TNFα but wane after a while (46) while others 
state that they are in general poor producers (47). Our 
findings though showed that there was no additional 
production of TNFα visible in the infected cell lines compared 
to uninfected (Figure 10). 
 
Figure 10: ELISA analyses for TNFα in the cell lines LL/2 and A549. The 
difference between infected cell line and uninfected cell line was compared to 
check for activation of TNFα. Data is representative of one experiment with three 
replicates in each group. 
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Adddition of TNFα 5h after the IAV infection led to a 
synergistic increase, while addition of TNFα at earlier time 
points did not. The addition 5h before or at the same time 
did not change the percentage in cell death (Figure 11).  
 
Figure 11: Looking at different time points of TNFα addition in LL/2 and A549 
cells. Only if TNFα is added 5h after the virus infection a synergism can be 
observed. The addition of TNFα 5h before or at the same time as the virus 
infection leads to no changes in the percentage of cell death compared to TNFα 
alone or IAV alone. Data is representative of one experiment with three 
replicates in each group. 
0
10
20
30
40
50
60
70
80
90
100
100 ng/ml 
TNFα
Virus 
alone
TNFα 5h 
after
TNFα 
same time
TNFα 5h 
before
%
 C
e
ll
 D
e
a
th
LL/2
Virus 1:1
Virus 1:10
TNFα alone 
0
10
20
30
40
50
60
70
80
100 ng/ml 
TNFα
Virus only TNFα 5h 
after
TNFα 
same time
TNFα 5h 
before
%
 C
e
ll
 D
e
a
th
A549
Virus 10:1
Virus 1:1
TNFα alone 
 3. Project 1  26 
3.2.3 Cytotoxicity of Influenza and TNFα in primary cells 
 
The synergistic effect of influenza virus and TNFα is 
consistent in all cell lines tested so we examined primary 
lung epithelial cells (LECs). After isolation we checked for 
the purity of the LECs to be sure that no immune cells were 
present during our experiment (Figure 12). All the cells 
expressed E-cadherin, a marker for epithelial cells, 
demonstrating a high degree of purity (48). 
 
 
Figure 12: Staining for LECs by DAPI (blue) and FITC-e-cadherin (green). 
Dense green lines between cells are accumulated e-cadherin (white arrows), 
which is needed for cell-cell adhesion. 
Using these cells to look at cell death led to 
complicated results. A 24-well plate showed us no negative 
or synergistic effect by the addition of TNFα (Figure 13). The 
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setup of a 96-well plate showed us the same synergistic 
result that we were able to see with our cell lines (Figure 
14). 
 
Figure 13: Primary lung epithelial cells being treated with IAV and TNFα in a 
24-well plate setup. The setup shows a reduction in cell death in IAV and TNFα 
treated cells. Data is representative of two independent experiments with one 
sample in each group. 
 
Figure 14: Primary lung epithelial cells being treated with IAV and TNFα in a 
96-well plate setup. The setup shows a synergistic effect of IAV and TNFα 
treated cells. Data is representative of one experiment with three replicates in 
each group. 
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Even a lower dose of IAV induced more cell death in 
the 24-well setup compared to the higher IAV in the 96-well 
setup. The TNFα induced cell death was four times lower in 
the 24-well setup than in the 96-well setup. Observing the 
cell density between both setups, 100 000 cells were more 
dense in the 24-wells than 10 000 cells were in the 96-
wells. This could be one reason for the different outcome. 
 
3.2.4 The impact of zinc on cell survival 
 
As mentioned in 3.1, zinc is known to be a cytoprotectant 
and an anti-apoptotic agent (32; 33) that enhances cell 
survival during infections (42). We therefore wanted to see 
if we can rescue the synergistic cell death that we were able 
to see with IAV and TNFα treatment. 
After determining the optimal concentrations of zinc 
for the cell lines we started our experiments (data not 
shown). Two setups were used to analyse the effect of zinc. 
The first setup had zinc pre-treated cells that received the 
zinc the night before the viral infection. With the second 
setup the cells received zinc only at the same time, as the 
viral infection occurred. Comparing the two setups showed 
us, that the earlier zinc is introduced to the cells, the more 
it helps the general survival of them. This could be observed 
by a reduced cell death of the zinc pre-treated cells 
compared to the cells that received zinc at a later time point 
(Figure 15). Zinc pre-treated cells had the lowest amount of 
cell death from all the experiments. Therefore the data was 
normalized to those cells. 
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Comparing the other treatments for changes in cell 
death gave us following results. Depleting the zinc after pre-
treating the cells with it and subsequently adding IAV alone 
or TNFα alone, led to a higher cell death in the cell lines 
compared to the cells that did not have any zinc at all. The 
stress induced due to the depletion might be the cause for 
that. However looking at the combined IAV and TNFα 
treated cells, we are neither able to see an increase of cell 
death after depletion of zinc, nor are we able to see a 
reduction in the percentage of cell death in the presence of 
zinc (Figure 15). 
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Figure 15: The cell lines LL/2 and A549 were either pre-treated with zinc or at 
the same time as the IAV infection. Zinc was removed from the pre-treated cells 
when IAV infection took place and only re added to rows indicated to have zinc. 
Pre-treatment led to a general higher cell survival. Depletion of zinc induced 
higher cell death in IAV infected and with the A549 in TNFα as well. No 
significant reduction of the synergistic effect from TNFα in combination with IAV 
can be observed. Data is representative of two independent experiments with 
three replicates in each group. 
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4 Project 2 – Influenza induced 
phagocytic defect in macrophages 
 
4.1 Introduction 
As already mentioned in 1.1, Influenza A virus induces an 
apoptotic cell death. Those dying cells then form apoptotic 
bodies, present molecules like phosphatidylserine on their 
cell surface and release chemo attractants (35; 49). These 
signals lead to the recruitment of macrophages to the lung 
which leads to a clearance of the apoptotic bodies by the 
macrophages (34). If these apoptotic bodies do not get 
cleared, they would turn secondary necrotic, leading to the 
release of pro inflammatory cytokines (35). Influenza, being 
able to infect alveolar macrophages as well as recruited 
monocytes/macrophages (2; 34), might have the potency to 
impair phagocytosis of these cells by macrophages. This 
would result in an inflammatory storm caused by secondary 
necrosis that is even further increased by coinfections. 
Comparing uninfected with infected macrophages for 
their phagocytic ability was done at first by a double stain 
experiment. Seeing a reduction in the uptake of the infected 
macrophages we used a 3rd stain to label dead 
macrophages. Therefore we could be sure that only alive 
infected macrophages were compared to uninfected 
macrophages in their ability to phagocytose dead cells.  
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4.2 Results 
4.2.1 Determining the right timing and amount of 
infecting macrophages with Influenza A Virus (IAV) 
 
To have an optimal infection during our phagocytosis 
experiments the amount of cell death induced by IAV was 
determined (Figure 16). The first ratio of influenza virus to 
macrophages used therefore was 1:3 for 20 hours. After our 
results became inconsistent with this ratio of infection, we 
realized that we had been using less macrophages than 
expected. The mistake simply happened by not counting the 
macrophages after they had been stained. During the 
staining process a lot of cells died and the actual numbers of 
seeded out macrophages were therefore lower than first 
calculated. In the end we found out that due to this mistake 
we had been using a ratio of 2:1 influenza virus for 20 hours 
instead. Finally we decided to use the 1:3 as well as the 2:1 
ratio of influenza infection over 20h for further experiments 
and compare the outcome to each other.  
 
 4. Project 2 
Figure 16: Determining 
phagocytosis experiments. Each square shows in the lower left: the percent of 
living cells; lower right: the percent of dying cells presenting Annexin V; top left: 
dead cells only labelled with PI; top right: dead 
Annexin V and PI. The orange numbers represent the percentage of cells in that 
area. Top row measured after 6h, middle row measured after 12h, bottom row 
measured after 24h.  
 
4.2.2 Influenza induced phagocytic defect in 
macrophages
 
As mentioned in 
epithelial damage and the following immunopathology seen 
in coinfected mice
macrophages to take up apoptotic bodies that then turn
secondary necrotic. IAV might be inhibiting a phagocytosis 
pathway. A ratio of 2:1 influenza virus was used to compare
infected and uninfected macrophages in their ability to take 
up IAV, etoposide or untreated LL/2 cells. 
were put together
 
the ideal ratio of IAV to macrophage to use for further 
cells double labelled with 
 
4.1, one reason for the immense lung 
, might be the inability of the 
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 with the macrophages over 1 hour, 2 
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hours and 4 hours
the conclusion that indeed an IAV infection seems to induce 
a defect in uptake (
 
 
 
Figure 17: Example of a
combination of 5:1 influenza infected, etoposide treated or untreated LL/2 cells
(from left to right lane)
macrophages (bottom ro
macrophages that are single stained and therefore
Black numbers represent macrophages that are double stained and therefore 
have taken up LL/2 cells.
Macrophages were stained with PKH26.
 
 
. The results that we received led us to 
Figure 187, Figure 18). 
 flow cytometry experiment. Showing 
 with either 2:1 infected (top row) or uninfected 
w). Yellow numbers represent the percent of 
 did not take up 
 LL/2 cells were stained with cell tracker green. 
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LL/2 cells. 
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Figure 18: 2:1 influenza Infected and uninfected macrophages are checked for 
their ability of phagocytic uptake from etoposide treated (top picture) and IAV 
infected LL/2 cells (bottom picture). The LL/2 cells were 1 hour, 2 hours or 4 
hours combined with macrophages before getting analysed. Data is 
representative of one experiment with one sample in each group. 
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4.2.2.1 Phagocytosis assay of living infected macrophages
 
In our experiment around 60 percent of the influenza 
infected macrophages die and are therefore not able to take 
up any LL/2 cells. Dying macrophages will still be labelled 
with PKH26 and will be counted as macrophages that have 
not taken up anything. This might cau
uptake between the infected macrophages and the 
uninfected ones. Gating only on our PKH26 labelled living 
cells (Figure 19)
consistent in 4 independen
use of a 1:3 ratio of virus to macrophages showed us 
opposite result. This indicated
sensitive an efficient IAV infection of the macrophages is 
essential for inducing the phagocytic defect
With the lower infection dose a higher uptake of LL/2 cells in 
the infected macropahges could be observed.
 
Figure 19: Flow cytometry setup for gating
macrophages (middle)
and 7aad can intercalate with the DNA
and they are therefore
 
 
 
se the difference in 
 then showed us that the results stayed 
t experiments (Figure 20
 that the experiment is very 
 (Figure 
 
 (left) on PKH26 labeled living 
. 7aad staining only occurs if cell membrane is breached
 (right). This only happens to dead cells 
 differently labeled than living ones. 
36 
). The 
an 
21). 
 
 
 4. Project 2 
Figure 20:  Only alive
for their ability of phagocytic uptake from etoposide treated (top picture) and 
IAV infected LL/2 cells (bottom picture). The LL/2 cells were 1 hour, 2 hours or 4 
hours combined with macrophages
independent experiments normalized 
varying background uptake.
experiments with one sample in each group. 
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Figure 21: Only alive
for their ability of phagocytic uptake. The LL/2 cells were 1 hour, 2 hours or 4 
hours combined with macrophages before getting analysed.
done in a triplicate setup. 
replicates in each group. 
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5 Project 3 – Macrophage motility 
 
5.1 Introduction 
During a lung infection with influenza, the clearance of the 
virus by macrophages is essential. The available 
macrophages in the lung would not be sufficient to counter 
the infection. Therefore more macrophages have to be 
recruited. The migration into the infected tissue is directed 
by chemokines (14; 50) that are released during a common 
immune response as described in 1.2. The binding of the 
chemokines to cell surface receptors of the macrophages, 
activate signalling cascades that lead to the activation of 
Phosphoinositide 3-kinase (PI3K). PI3K then leads to the 
production of Phosphatidylinositol (3,4,5)-trisphosphate 
(PIP3). This is essential for the formation of actin filaments 
that direct the movement of the macrophages by forming 
filopodia. 
As influenza virus is known to interact with PI3K (51), 
we wanted to analyze how infected macrophages would act 
differently in their motility compared to uninfected 
macrophages. Our live imaging experiments showed us that 
infected macrophages possibly release chemokines into the 
surroundings, as they are able to change the movement 
pattern of uninfected macrophage. We were also able to see 
a reduction of the movement speed of infected macrophages 
compared to uninfected Macrophages. 
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5.2 Results 
5.2.1 Macrophage motility 
 
Macrophages are essential in the immune response to 
influenza. Therefore we were interested in studying how 
infected macrophages changed their motility after infection. 
Surface staining of the viral M2 protein showed that all the 
macrophages were infected (Figure 22). By analysing their 
movement over 18h we could clearly see that the colony of 
infected macrophages did not spread far from the starting 
point, while uninfected macrophages spread out from the 
initial colony (Figure 23; Figure 24; Figure 25).  
 
 
 
Figure 22: Uninfected macrophages (left) and infected macrophages (right) 
compared for the presentation of the viral M2 cell surface protein. An overlay 
(middle) shows a clear shift of the whole peak to the right for the infected 
macrophages (green line). 
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Figure 23: Uninfected macrophages (A) and infected macrophages (B) at 0h of 
the live imaging analyses. Data are from one live imaging experiment. 
  
Figure 24: Uninfected macrophages (A) and infected macrophages (B) at 8h of 
the live imaging analyses. Data are from one live imaging experiment. 
  
Figure 25: Uninfected macrophages (A) and infected macrophages (B) at 18h 
of the live imaging analyses. Data are from one live imaging experiment.  
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5.2.2 Influence of infected macrophages on uninfected 
macrophages
 
To check if the movement deformation was directed by the 
infection, PKH26 labeled uninfected macrophages were put 
together with unlabeled infected macrophages in one 
colony. Live imaging over 18h showed us
macrophages act
No difference in the
 
Figure 26: PKH26 uninfected macrophages (yellow) and infected macrophages
(transmission) compare to each other
(A), 6h (B), 12h (C) and 18h (D) time points. 
experiment. 
 
 
 motility 
 that uninfected 
ed like infected macrophages (Figure 
 spreading could be observed.  
 
 
 in one colony over 18h. Pictures show 0h 
Data are from one live imaging 
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5.2.3 Differences in speed of infected macrophages 
compared to uninfected macrophages
 
The next step was to see if there is a diff
movement speed of macrophages during a colony spread. 
We therefore took shorter time intervals to be able to follow 
the macrophages from one picture to the next one. There 
was an observable difference between the uninfected and 
infected macrophages. Infected macrophages were around 
25µm/h slower than uninfected macrophages
 
Figure 27: Speed measurement of uninfected macrophages (left) 
macrophages (right).
macrophage over a time period of 1h, placing one square every 10min.
macrophages were manua
imaging experiment. 
Again also the movement direction showe
spreading movement away from the colony by the 
uninfected macrophages. Infected macrophages in 
comparison were 
stayed close to the colony.
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6 Discussion 
 
Coinfections are very complex and manifest differently 
between different types of pathogens. Therefore we have 
not covered all mechanisms and possibilities involved during 
these infections. Our results though are the first step of 
putting the pieces of the Influenza A virus and L. 
pneumophila coinfection puzzle together. 
We showed a synergistic effect on cell death in our 
lung epithelial cell lines between TNFα and IAV infected cells 
(Figure 6, Figure 7). Showing that this effect is only visible if 
the TNFα is added 5h after the infection of the virus (Figure 
11), demonstrates that viral infection alters the intracellular 
machinery in some way, that the addition of TNFα then 
causes the cell to follow an apoptotic pathway. One reason 
for the enhanced cell death could be the expression of type 
1 Interferons (IFN-α/β), which as mentioned under 1.2, act 
to form an antiviral state (14) and are known to prime 
macrophages to become susceptible to further apoptosis or 
necrosis (52; 53). Knowing what the different influenza viral 
proteins are able to do, (9-11; 54) we cannot exclude a 
possible correlation between one or more yet unknown 
functions of the viral proteins and in that case a direct 
transformation of the TNFα pathways. Already other 
bacterial and viral strategies have been identified to 
manipulate the TNFα induced pathways (38) (Figure 28). 
Influenza might regulate the NF-κB pathway and in that 
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case TNFα would not be able to induce the production of 
survival signals but would only be able to induce cell death. 
Another possibility would be the viral NS1 protein which is 
able to regulate cell survival. First it blocks apoptotic 
pathways by inhibiting p53 and after replication and spread 
of new virus it induces cell death (9). TNFα stimulates 
accumulation of p53 (55), which in that case might 
overcome the regulation by the NS1 protein. This would lead 
to an increased cell death of the viral infected cells. It could 
be though that influenza is not regulating the pathways that 
lead to apoptosis by TNFα. It might rather try to inhibit their 
activation by blocking the translation of TNFα. There is a 
study that proposes that TNFα mRNA gets highly produced 
after influenza infection but only is released efficiently as a 
protein after lipopolysaccharide (LPS) stimulation (56). 
Already highly stressed cells having to deal with higher 
levels of TNFα, might then push them into an apoptotic 
pathway. Therefore these higher levels of TNFα during 
coinfections (31) compared to a viral infection alone might 
be an answer. 
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Figure 28: Showing different strategies of viral and bacterial proteins to 
influence TNFα induced pathways (38). 
Source: Rahman MM, McFadden G. Modulation of Tumor Necrosis Factor by Microbial 
Pathogens. PLoS Pathog 2006 Feb;2[2] 
 
 
The results that we received from our primary cells 
were inconsistent. Having both a synergistic effect similar to 
the cell line data (Figure 14) but on the other hand having a 
rescue effect by TNFα (Figure 13). The difference between 
the experiments was obviously the well size as we once 
used a 96-well plate and once a 24-well plate. The cell 
density might be the key difference between the 
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experiments and what cell density corresponds to the lung 
environment is an important question to address. This has 
to be checked in further experiments. 
   
We next examined if we can rescue the cells from this 
synergistic effect that we saw with our cell lines. Finding a 
way to counteract in vitro against the deadly effect of TNFα, 
would give us a chance to try and enhance the survival of 
coinfected mice in vivo. We therefore tried zinc, which as 
mentioned in 3.1 is a cytoprotectant and anti apoptotic 
agent (32; 33). It interacts directly with caspase-3 which is 
one of the targets to be activated by IAV and TNFα. (44; 
43). The different approaches of either pre-treating our cells 
with zinc or adding zinc at the same time, as the infection 
took place, did not show us a rescue against the synergistic 
effect (Figure 15). However, if the zinc was removed from 
the cells after pretreatment, they were indeed more 
susceptible to IAV & TNFα induced cell death. This could be 
one of the things happening in vivo, as during bacterial 
infections the zinc levels get reduced (40). 
Trying different timings of when zinc is added could 
give us more relevant information for a possible role of zinc. 
For example we could try to culture the cells in zinc 
supplemented medium for a week. This might change the 
intracellular response to pathogens even further than just 
pre-treating them for one night. The depletion of zinc could 
in that case show us an even stronger negative effect. The 
depletion of zinc 5 hours after IAV infection, when TNFα is 
added, would also be very interesting to see. This would 
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reflect even better what we are able to see during 
coinfections. Further it might cause an even more drastic 
difference compared to cells where the depletion was 
counteracted by addition of more zinc. The last approach 
could be by looking at the in vivo situation by giving mice a 
zinc supplemented diet and look at the death rate of the 
mice after coinfections. 
 
All our experiments were done in vitro which is much 
different than the in vivo situation. The cells were without a 
functional immune system and had no real way to counter 
the viral onslaught. So we were not able to know if TNFα is 
the only key element in the immunopathology that is going 
on in vivo. In vivo experiments done in TNFα knockout mice 
by Amanda M. Jamieson (unpublished data), showed the 
single infected mice did not have any defect in their 
capability of surviving a sublethal dose. The coinfected did 
not show an increase in survival and all mice died at the 
same time as wildtype mice (Figure 29). However, it is clear 
that the synergism between IAV and TNFα exists in vitro and 
may contribute in some way to the deadly outcome of 
coinfected mice. However, other factors also appear to play 
a role during an actual coinfection. 
 
 6. Discussion 
Figure 29: TNFα knockout mice treated 
Legionella and coinfecti
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sensitive experiment cannot be excluded. However, the 
possibility remains that only an efficient infection of the 
macrophages leads to an inhibition of the phagocytic ability, 
which was only seen with the higher dose of IAV. But as 
neither in vitro primary cell, nor in vivo experiments have 
yet been executed from our side to provide us with more in 
depth information of the actual happenings, further 
examinations have to be made. This is important as BMDM 
might have different ways to react to an IAV infection than 
would normal alveolar macrophages (AM). In addition, using 
primary lung epithelial cells, which also might act different 
than tumor cell lines, may allow us to look at a more 
physiological response. 
What has not been addressed in this diploma thesis 
but would also be interesting to look at is if infected 
macrophages have reduced numbers or completely missing 
cell surface receptors, which would be needed to bind and 
take up dead cells. The removal of these receptors could be 
accomplished by the viral NA which, as mentioned in 1.1, is 
known to be responsible for cutting sialic acids on the cell 
surface to bud off. 
The last thing that caught our attention was IL-10, 
which is known to suppress TNFα expression and also 
enhance the phagocytic ability of macrophages (57; 58). 
Final results showed us that infected macrophages seem to 
express less IL-10 compared to uninfected macrophages 
(data not shown). To check for the actual mRNA level of IL-
10 will be the first step here. This might already show 
differences to the measured supernatant. From there it will 
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be immensely interesting to see if the reduction of IL-10 
proves to be true in vivo as well. If this would be the case, 
then this could be a reason for a reduction of the 
phagocytosis that we have seen. Further it might give us an 
idea of why we see an immunopathology that with a normal 
expression of IL-10 might not happen. 
 
Clear results came from the movement of the infected 
macrophages. Uninfected macrophages had a directed 
movement away from the colony, while IAV infected 
macrophages stayed close to the colony and had a reduced 
spreading movement. We then examined if this effect was 
cell autonomous. It might also be that this pattern is 
induced through to release of chemokines, as mentioned in 
1.2, which would influence the movement of uninfected 
macrophages if presented to them. Combining uninfected 
macrophages with infected macrophages in the same 
colony, led to an adjustment of the uninfected macrophages 
to the infected macrophages. Both movement patterns 
became the same (Figure 26). Our first thought of 
chemotaxis directed movement seemed to be reasonable.  
Future experiments should give us more insight into 
the possible mechanisms for this phenomenon. Optimizing 
the colony spreading experiment would be the first step 
here. This could be done by looking at the whole colony 
while it is spreading, instead of looking only at a small 
fraction of the colony. Next thing would be to use chemo 
attractants or the supernatants of infected macrophages. 
They would be added to uninfected macrophages. If their 
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movement pattern would change, this could prove that 
chemokines are responsible for the alteration in the 
movement of the macrophages. During infections this would 
lead to a macrophage infiltrate into the infected region. The 
production of further chemokines would therefore attract 
even more macrophages. This high number of macrophages 
would be necessary to clear the infection. Higher amounts of 
macrophages also means higher amounts of inflammatory 
cytokines produced and this might be one of the reasons for 
the immunopathology that we see. 
In addition to the observable difference in the type of 
movement, the actual speed of the macrophages proved to 
also be interesting. The difference that could be seen not 
only showed us a reduction of over one quarter of the 
uninfected macrophage speed but also again a zigzagging 
movement pattern by the infected macrophages, compared 
to a more outward bound movement by the uninfected 
macrophages (Figure 27). There are several possibilities for 
these observed differences that will require further research 
to confirm. During our experiments we were able to observe 
that infected cells are generally more adherent than 
uninfected ones, one of the reasons could be that one of the 
viral proteins leads to an increased adherence of the 
macrophages, which makes it harder for them to move on. 
Another possibility and simple answer could be that the 
macrophages are already close to death and therefore have 
a highly reduced motility. This though can most likely be 
excluded as we only looked at macrophages which still 
showed their filopodia and therefore were alive. An 
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additional 7-aad staining would make it easier to only count 
living macrophages. For more accurate results of the speed 
measurement, a computer tracking software which is able to 
track every single cell over an even longer period of time, 
would be needed.  
If we look at the big picture now, we can say that one 
mechanism alone is not capable of leading to the 
immunopathology that we see in vivo. In fact it is very likely 
that all the mechanisms are linked to each other. First we 
have an influenza infection in the lung. The immune 
response leads to the production of chemokines, attracting 
macrophages to the site of inflammation (Project 3). There 
the macrophages get infected and therefore are weakened 
in their ability to phagocytose dead cells (Project 2). Under 
normal circumstances, they would still be able to handle the 
infection. During coinfections this is different. Once the 
bacterial infection takes place, it triggers the higher release 
of TNFα. The combination of viral infection and TNFα leads 
to a higher cell death (Project 1). This is too much to 
phagocytose for the infected macrophages, leading to the 
release of pro-inflammaory cytokines and subsequently to 
immunopathology. Unraveling more interactions during 
coinfection, which are linked to the ones we have identified, 
will be very interesting in the future. 
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7 Materials and Methods  
 
7.1 Mice 
C57BL/6 (B6) mice were obtained from Charles River. 
They were between 6 and 10 weeks old. 
 
7.1.1 Bone marrow derived macrophages (BMDM) 
 
  The BMDM were taken from the tibia and the femur of 
B6 mice and cultured in DMEM (PAA) supplemented with 
10% FCS (Sigma), 10% L.condition, Penicillin and 
Streptamycin (Invitrogen) in 100mm square Petri dishes 
(Sterilin). Supernatant from L929 cells was a source of 
colony stimulating factor-1 (CSF-1) used to grow BMDM. 
(59). 
 
The cells were fed after day 3 with 5ml medium. On 
day 5-7 they were scraped off and split into three times the 
amount of dishes. Between days 10-18 the BMDM were 
seeded out for further experiments. 
 
1000x Pen/Strep: 0,06%  Penicillin 
    0,1% Streptamycin 
Dissolved in 1ml H2O 
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10x PBS:   81mM Na2HPO4.2H2O 
    15mM KH2PO4 
    25mM KCl 
    1,4M NaCl 
    pH = 7,4 
 
 
7.1.2 Primary Lung epithelial isolation (46) 
 
On the day before the isolation of the lungs a 100mm 
tissue-culture-treated Petri dish (Nunc) was coated with 
50µg of CD45 rat anti-mouse Antibody (Becton Dickins) and 
40µg of CD16/32 anti-mouse Antibody (Becton Dickins) in 
5ml PBS. Additionally untreated cell culture plates or 
chambers (Nunc) were coated with Collagen IV (Sigma) at a 
concentration 1µg/ml. Both plates were then sealed with 
either fresh keeping foil or parafilm and placed at 4oC over 
night. Directly before their use, the plates were washed 2 
times with PBS. 
 
To avoid disturbing the trachea mice were euthanize 
with CO2. Using a dissection board the 70% ethanol cleaned 
mouse was cut open at the peritoneum. From there the 
diaphragm was cut out carefully to not injure the lungs. The 
sides of the ribcage were cut to ensure a good access to the 
heart. Fat was removed from around the heart and a cut 
was executed at the vena cava, which can be found at the 
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top left part of the heart. This is to prevent any backflow 
from flushing the heart. The right chamber of the heart was 
now invaded with a 0,8mm needle to perfuse the lung, thus 
clearing them of blood cells, with 20ml NaCl. Now the 
airway was exposed and after removing additional tissue, a 
hole was cut into the trachea. A piece of suture thread was 
wrapped around the airway and pulled tight after inserting 
3ml Dispase I with a flexible silicon tube (Helixmark) 
connected to a syringe, to avoid the backflow of the Dispase 
I. Through the same silicon tube, 0,45ml of the LMP agarose 
was very carefully inserted, to not mix it with the Dispase. 
Ice was then used for 2 mins to polymerize the LMP 
agarose. The lung was cut out and placed in 1ml Dispase for 
45min at room temperature. After that time, it was placed 
on ice until further use. 
The lung was taken out into a 100mm Petri-dish with 
7ml of DMEM + 0,01% DNase I and 2 bent forceps were 
used to rip the lung into tiny pieces. The cell isolate was 
taken up with a 10ml syringe and filtered two times through 
70µm mesh filter (Becton Dickins), mashing it through with 
the back side of a 2,5ml syringe. The cells were then 
centrifuged at 130g for 12min at 4oC. After that the 
supernatant was taken off and the pellet was resuspended 
in 10ml DMEM + 10% FCS. The cell suspension was then 
poured into the CD 16/32/45 coated Petri-dish and 
incubated at 37oC for 2 hours. 
The supernatant was collected and 1ml was used to 
determine the total cells via Vi-Cell, Cell viability Analyzer 
(Beckman Coulter). After that the cells were centrifuged at 
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130g for 12min at 4oC. They were then taken up in Ham´s 
F12 medium in a concentration of 1.105 cells/ml. Now either 
1ml/well was added to a 24 well plate or 100µl/well to a non 
collagen coated 96 well plate. 
The next day the medium and all non adherent cells 
were sucked off and fresh Ham´s F12 medium was added 
for optimal conditions. This was repeated 2 times, with 3 
days in between, until further experiments were started. 
 
0,9% NaCl:   0,9g  NaCl 
100ml ddH2O 
     Sterile filtered 
 
1% low melting agerose: 1g Low melting point (LMP) 
agarose 
     100ml ddH2O 
     Autoclaved 
20 minutes before use keep at 
37oC water bath 
 
Dispase I (Sigma):  2mg  Dispase I 
     20ml  PBS 
     Sterile filtered 
     Kept 5ml aliquots at -20oC 
 
 
DMEM + 0,01% DNase I (Sigma): 10mg DNase I 
      100ml  DMEM 
      Sterile filtered 
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DMEM + 10% FCS:  500ml DMEM 
     50ml FCS 
     500µl Pen/strep 
 
Ham´s F12 medium:  15mM  Hepes 
     0,8mM CaCl2.2H2O 
0,25% Bovine  Serum 
Albumin (BSA) 
 
Used I1884 Sigma: 
     5µg/ml  Insulin 
     5µg/ml Trsansferring  
     5ng/ml Sodium selinite 
 
     10%  FCS 
pH = 7,4 
Sterile filtered 
 
7.1.2.1 Staining for primary Lung epithelial cells (LECs) 
 
Lab-Tek 4 Well Permanox Chamber slides (Nunc) were 
coated with 500µl Collagen IV (Sigma) at a concentration of 
1µg/ml. Before further use the chambers were washed 2 
times with 1ml PBS. Taken up in Ham´s F12 medium, 1.105 
cells were added to each chamber. 
The next day the medium and all non adherent cells 
were sucked off and fresh Ham´s F12 medium was added 
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for optimal conditions. This was repeated 2 times with 3 
days in between. 
On day 7 the chambers were washed 2 times with 
PBS. Afterwards the cells were fixed using 1ml 3% PBS/PFA 
(Paraformaldehyd) for 10min. The cells were washed 2 
times with 1ml PBS and then 0,1% Triton was added to 
permeabalize the cell membrane for the antibody (AB). The 
cells were again washed 2 times with 1ml PBS and then 
blocked for 1h using 5% milk. 
After blocking, the cells were washed 2 times with 1ml 
PBS. The primary AB, purified mouse anti-E-cadherin 
(Becton Dickinson), was added in 300µl of 3% BSA with a 
concentration of 5µg/ml (1:50 dilution) to the first 2 
chambers. The second 2 chambers received only 300µl of 
the 3% BSA as controls. The chamber slide was wrapped in 
parafilm and placed on a slow shaker on 4oC over night. 
On the next day the chamber slide was washed 2 times with 
1ml PBS for 5 minutes. The secondary AB, chicken anti-
mouse AB alexa fluor 488 (Becton Dickinson), was added in 
1ml of 5% milk with a concentration of 4µg/ml (1:500 
dilution) to the first 3 chambers. The last chamber only 
received 1ml of 5% milk. The incubation was done at RT in 
the dark for 1h. 
The cells were washed 2 times with 1ml PBS for 5 
minutes and then stained with 1ml of a concentration of 
0,3µg/ml (1:3000 dilution) DAPI diluted in PBS. The 
incubation was done at RT in the dark for 10min. The cells 
were washed once more with 1ml PBS. Immediately 
afterwards the construct on top of the slide was ripped off 
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and 2 drops of darko fluorescent mounting medium (Dako) 
was added onto each chamber area. Very carefully a 24 x 
50mm cover slip was lowered onto the slide, pushing all air 
out of the area. 
The slide was then placed at RT in the dark over night 
to let the mounting medium harden. Once hardened the 
slide was looked at with the Olympus Cell-R Live Imaging 
Unit (Olympus) with an amplification of 10. 
After use the slide was kept at 4oC in the dark. 
 
5% milk:    0,25g milk powder 
    5ml PBS 
 
3% BSA:   3g BSA 
    100ml PBS 
    Sterile filtered 
 
4% PBS/PFA:  4g paraformaldehyde 
    100ml PBS 
    Dissolve it under constant stirring 
    Once dissolved keep at 4oC 
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7.2 Viral Strain 
The A/WSN/33(H1N1) strain of influenza A virus was 
originally obtained from the laboratory of Dr. Akiko Iwasaki. 
(31) 
 
7.2.1 Propagation of Virus (60) 
 
MDCK cells were grown until they were confluent in a 
75cm2 cell culture flask (Nunc). They were lifted off by 
Trypsin-EDTA (PAA) and taken up in 40ml medium. 2ml 
medium with cells was added to each well of three 6-well 
multidishes (Nunc). 4ml were used to keep MDCKs growing. 
On the next day the medium was aspirated off using 
autoclaved Pasteur pipettes. The wells were then infected 
with 200 PFU of virus in 100µl of DMEM with 1% BSA (MP 
Biomedicals). The 100µl were spread by shaking the dish 
and left on for 5-10 minutes. Another 1,5ml of DMEM+BSA 
was added and the dishes were left to incubate at 37oC with 
5% CO2. After 48h the supernatant of each well was 
harvested and pooled into 50ml tube (Falcon). The cell 
debris was spun down by centrifuging at 2000rpm for 
10min. The supernatant was removed to another 50ml tube 
and subsequently aliquoted into Cryo tubes (Nunc) that 
were frozen down at -80oC. 
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7.2.2 Plaque Assay for WSN Influenza Virus 
 
MDCK cells were grown until they were confluent in a 
75cm2 cell culture flask (Nunc). They were lifted off by 
Trypsin-EDTA (PAA) and taken up in 40ml medium. 2ml 
medium with cells was added to each well of three 6-well 
multidishes (Nunc). 4ml was used to keep MDCKs growing. 
The virus was diluted into 1:10; 1:1.102; 1:1.103; 1:1.104; 
1:1.105 concentration using PBS+BSA buffer. MDCK cells 
were washed once with PBS. Then each dish was infected 
with 100µl of each virus dilution and one well with PBS+BSA 
buffer as negative control. The cells were incubated for 1h 
at 37oC with 5% CO2. Every 10-15min the dishes were 
shaken to avoid drying. During incubation the overlaying 
mixture was prepared and, as well as the 2% low melting 
agerose, kept at 37oC water bath at least 20min before 
further use. 
After the incubation the virus was aspirated and the 
overlying mix was combined with the low melting agerose. 
2ml of the mixture was added to each well immediately. The 
dishes were kept at room temperature with open lid for 
around 5min to let the agar solidify. The dishes were then 
incubated upside down for 2-3 days at 37oC with 5% CO2. 
After the incubation the plaques were counted to acquire the 
virus concentration. 
 
100x Ca/Mg:   1,327mg CaCl2 
     2,133mg MgCl2 
     100ml H2O 
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PBS+BSA:     0,315mg  BSA  
     1,5ml 100x Ca/Mg 
     148,5ml  1x PBS 
     Sterile filtered 
 
2x DMEM+BSA:   12g DMEM powder 
     1,2mg NaHCO3 
     2,1mg BSA 
     500ml ddH2O 
     Sterile filtered 
 
1% DEAE-dextran:  1mg DEAE-dextran 
     100ml ddH2O 
     Sterile filtered 
 
5% NaHCO3:   5mg NaHCO3 
     100ml ddH2O 
     Sterile filtered 
 
2% low melting agerose: 2mg low melting agerose 
     100ml ddH2O 
     Autoclaved  
  
Overlaying mixture:  25ml 2x DMEM+BSA 
     0,5ml 1% DEAE-dextran 
     1ml 5% NaHCO3 
     25µl trypsin (Gibco) 
     0,5ml Pen/Strep 
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7.3 Cell lines 
The cell lines A549 (carcinomic human alveolar basal 
epithelial cells), LL/2 (Lewis lung carcinoma passaged 
routinely in C57BL6 mice) and MDCK (Madin-Darby canine 
kidney) were cultured in DMEM (PAA) with 10% FCS 
(Sigma), Penicillin and Streptamycin (Invitrogen) in cell 
culture flasks (Nunc) of sizes between 25cm2 and 175cm2, 
dependent on the amount of cells needed for the 
experiments. They were split every 2-3 days using Trypsin-
EDTA (PAA) to lift hem off. 
 
The cell lines MLE12 (alveolar lung epithelial) and 
MLE15 (bronchial lung epithelial) were cultured in RPMI1640 
supplemented with 2% FCS (Sigma), Penicillin and 
Streptamycin (Invitrogen), 2,5ml of Insulin, transferring and 
sodium selenite (Sigma I-1884), 250µl of Transferrin 
(Sigma T-1428), 50µl of Hydrocortisone (Sigma H-0888) 
and 50µl of b-Etradiol (Sigma E-2758) in cell culture treated 
60mm Petri dishes (Falcon). They were split 1:5 every 3 
days using PBS supplemented with 2mM EDTA (Sigma), 
added from a 500mM EDTA stock solution, to lift them off. 
 
7.3.1 Mycoplasma test and treatment 
 
Five ml of cell culture supernatant was taken up and 
centrifuged at 1500rpm for 5min. 500µl supernatant was 
taken and used for analyses with a luciferase assay (61). If 
cells were tested positive, they were treated with ciproxin in 
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a 1:500 dilution for 10 days. The antibiotics were changed 
every 2 days. 
 
7.4 Freezing and thawing of cells 
Cells were spun down with 1400 rpm for 5min and 
supernatant was removed. The cells were then taken up in 
90% FCS and 10% DMSO. 1ml of the cell suspension was 
put per cryotube and placed at -80oC immediately. When 
cells are being used again they are thawed fast and mixed 
with their working medium to be placed in their incubator as 
normal. 
 
7.5 Live imaging 
The macrophages were counted with the Vi-Cell, Cell 
viability Analyzer (Beckman Coulter) and taken up in 
Macrophage medium (see 7.1.1), to have 1.106 cells/ml. 
Imaging was done on uninfected and infected macrophages. 
Infected macrophages were incubated for 20h with 1:3 
influenza virus before the live imaging was started. 
Two pyrex cloning cylinders of the size of 6mm x 8mm 
(Sigma Aldrich) each were placed on a 35mm poly-d-lysine 
coated gamma irradiated glass bottom culture dish with 
14mm glass and No. 1.5 glass thickness  (MatTek 
corportaion). Exactly 100µl, were then inserted into each of 
the cylinders, without touching or moving them. Having the 
front of the tip touch the glass ensured that no air bubbles 
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were formed and cells could spread evenly. Two– 2 ½ hours 
later a Pasteur pipette was used to suck off the medium and 
lift off the cloning cylinder, to not disturb the now formed 
colony. 2ml of fresh medium was inserted at the edge and 
distributed over the plate. The live imaging was done with 
the Olympus Cell-R live Imaging Unit with an amplification 
of x10. The cells were kept in an incubation chamber (40oC 
lid; 38oC bottom) with 5% CO2. Pictures were made every 
30min over time periods of 18h. 
 
 
7.5.1 Measuring the speed with live imaging 
 
The procedure for analyzing was mentioned in 7.5. 
Differences were: Infected macrophages were treated with 
2:1 influenza virus before the live imaging was started. 
Pictures were made every 5min over a time period of 4h. 
Coral Photo-Paint 12 was used to evaluate the speed. 
7 pictures were placed over each other. The time window 
from one picture to the next was 10min. A square was 
drawn over the center of a macrophage in a certain color. 
Then the top picture was faded out and the next square was 
drawn over the new center of the macrophage. This was 
repeated for all 7 pictures. Only macrophages that formed 
filopodia were taken into account. The picture was then 
printed out and distances were measured with a ruler, 
taking the distance from the middle of one spare to the 
middle of the next square.  Knowing the millimeter to 
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nanometer ratio the speed was calculated taking the mean 
of all measured macrophages. 
 
7.6 LDH-Assay (45) 
LDH is released from dead cells and can then be 
measured by adding Lactate which is oxidized to Pyruvate 
forming NADH. In addition with Tetrazolium salt, Formazan 
is being formed which then can be measured to estimate the 
cell death percentage.  
 
7.6.1 Analysing cell death from IAV and/or TNFα 
treatment  
 
LL/2, A549, MLE12, MLE15 and primary LECs were 
used to determine the effect of IAV and/or TNF-a treatment. 
The experiments were done in 96well plates. In 100 µl 10 
000 cells/well were seeded out for the A549, MLE12, MLE15 
and primary LECs. For the LL/2 cells 5000 cells/well were 
seeded out. 
On the following day, the IAV was used 10:1 for A549, 
1:1 for A549, LL/2, MLE12, MLE15 and 1:10 for LL/2, 
MLE12, MLE15 and primary LECs. All cells were infected with 
IAV for 24h before the lyses solution was added. 
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 Flu 
10:1/1:1/1:10 
Flu 
1:1/1:10/1:20 
No flu + 50µl 
Medium 
No flu/No TNFα 
+ 100 µl 
Medium 
A             
B             
C             
D             
E          Only Medium 
Background 
control 
F          
G          
Lysis Solution 
Positive control 
H No TNFα + 50µl 
Medium 
No TNFα + 50µl 
Medium 
No TNFα + 50µl 
Medium 
Figure 31: different setups used for analyzing the impact of IAV and TNFα on the cell death of 
different cell lines. Highest TNFα concentration (100ng/ml or 33ng/ml) was added in row A and was 
diluted 1:3 for every further row until row G. 
 Flu 10:1/1:1 Flu 1:1/1:10 No flu + 50µl 
Medium 
No flu/No TNFα 
+ 100 µl 
Medium 
100ng 
TNFα 
No TNFα + 
50µl Medium 
No TNFα + 
50µl Medium 
      
+5h             
0h             
-5h             
10ng 
TNFα 
No TNFα + 
50µl Medium 
No TNFα + 
50µl Medium 
   Only Medium 
Background 
control +5h          
0h          Lysis Solution 
Positive control -5h          
Figure 30: different timings used for analyzing the impact of IAV and TNFα on the cell death of cell 
lines LL/2 and A549. TNFα was added in either 100ng/ml or 10ng/ml concentrations. The addition 
of TNFα occurred either 5 hours before the virus infection (-5h), at the same time as the virus 
infection (0h) or 5 hours after the virus infection (+5h). 
Murine TNFα (Sigma) was added 5h after the IAV 
infection. It was used in different concentrations starting at 
100ng/ml and going down in 1:3 steps for A549, LL/2 and 
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primary LECs. For MLE12 and MLE15 the used TNFα 
concentration started at 33ng/ml and went down in 1:3 
steps (Figure 31). For LL/2 and A549 cells additional timings 
of TNFα were used. TNFα was added 5 hours before, at the 
same time and 5 hours after the IAV infection (Figure 30). 
 
Murine TNFα (Sigma):    10ug/ml Stock 
      Keep at -20oC  
 
7.6.2 Analysing the impact of zinc on the amount of cell 
death from IAV and/or TNFα treatment  
 
The cell lines LL/2 and A549 were used to determine 
the impact of zinc on the effect of IAV and/or TNFα. 
Experiments were done in 96well plates. In 100µl, 10 000 
cells/well were seeded out for the A549 and 5000 cells/well 
were seeded out for the LL/2 cell line. On the following day, 
the IAV was added in 10:1 (for the A549) or 1:1 (for the 
LL/2) concentration. The cells were incubated for 24h at 
37oC before lyses solution was added. 
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 Flu 10:1/1:1 + 
50µl Medium 
Flu 1:1/1:10 + 
0,05mM zinc 
0,05mM zinc + 
TNFα 
TNFα + 50µl 
Medium 
A             
B             
C             
D             
E             
F             
No 
TNFα 
         No flue/No 
TNFα + 100 µl 
Medium H Lysis Solution 
Positive control 
Only Medium 
Background control 
Figure 32: Zinc, IAV and TNFα were used in different combinations on the cell lines LL/2 and 
A549. Highest TNFα concentration (100ng/ml) was added in row A and was diluted 1:3 for every 
further row until row F. 
 
Murine TNFα (Sigma) was added 5h after the IAV infection. 
It was used in different concentrations starting at 100ng/ml 
and going down in 1:3 steps. Zinc was added either the 
night before the IAV infection or at the same time as the 
IAV infection (Figure 32). When zinc was added the night 
before the IAV infection,  rows which had only flu (green) 
and only TNFα (blue) the medium was exchanged to normal 
DMEM + 10% FCS before the infection with IAV. 
 
1mM zinc (Merck):  0,7mg  zinc sulphate 
heptahydrate 
50ml DMEM + 10FCS 
Sterile Filtered 
 
 
 7. Materials and Methods  71 
Well – untreated cells 
                    _______________________       x100 
Max lysis – untreated cells 
7.6.3 Evaluating the LDH-Assay (45) 
 
50µl of the supernatant of each well of the 96-well 
plate was transferred into a new 96-well plate. 50µl of the 
mixture of Assay Buffer and Substrate mix was added to 
each well and kept in the dark at RT for 30 minutes. After 
that 50µl of stop solution was added. 
The absorbance was measured at 492nm for 0,1s/well 
with the Wallac Victor2 1420 Multilabel counter (Perkin 
Elmer). The data was exported from Wallace workstation to 
be analysed in Microsoft Excel.  
The average background from the medium was 
subtracted from all other wells. Now the following equation 
was used to determine the amount of cell death per well: 
 
 
7.7 ELISA  
We used a commonly available sandwich ELISA 
(DuoSet, RnDSystems) to measure the supernatants of 
LL/2, A549 cells alone and from the combined phagocytosis 
assay. The absorbance was measured at 450nm for 
0,1s/well with the Wallac Victor2 1420 Multilabel counter 
(Perkin Elmer). The data was exported from Wallace 
workstation to be analysed in Microsoft Excel. 
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7.7.1 TNFα 
 
The cell lines LL/2 and A549 were tested for TNFα. The 
supernatant was taken after 24h IAV infection with the 
doses of 10:1/1:1 for A549 or 1:1/1:10 for LL/2. The 
supernatant was then frozen at -80oC until further use. 
 
7.7.2 IL-10 
 
All wells of the 6-well plate from combination points 1h, 
2h and 4h of the phagocytosis assay were tested for IL-10. 
The Supernatant was taken at the end of the combination 
time. It was then spun down at 14000rpm for 90 seconds to 
get rid of any cell debris. The supernatant was transferred 
into a new eppendorf tube and frozen at -80oC until further 
use. 
     
7.8 Flow cytometry (FCM) 
The used machine was a FACS Calibur (Becton Dickins) 
with 2 emission spectra of 488nm and 635nm. The 
fluorescent materials used were excited and detected with 
following channels: (62; 63) 
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 Exitation Emission Color 
FACS Calibur 
Laser 
- 
488nm & 
635nm 
- 
PI  488nm 617nm Red (FL2/FL3) 
FITC 495nm 521nm Green (FL1) 
APC 633nm 660nm (FL4) 
PE 495nm 575nm 
Orange-red 
(FL2) 
PKH26 488nm 567nm Orange (FL2) 
Cell tracker 
green 
492nm 517nm Green (FL1) 
7aad 488nm 647nm Red (FL3) 
    
 
FL 1 530 +/- 30nm 
FL 2 585 +/- 42nm 
FL 3 670 Long pass 
FL 4 661 +/- 16nm 
 
The data was analysed on a Mac computer with the cell 
quest pro software. 
  
FACS-Buffer:   500ml PBS 
     1%  BSA 
     0,01% Sodium Acid 
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7.8.1 Measuring macrophage cell survival 
 
Macrophages were split into 3x6 well non-tissue 
culture treated plates (Becton Dickins) having 3.105 
macrophages per well. The macrophages were then infected 
with IAV on the same day at 17.00, on the next day at 6.00 
and 11.00 with concentrations of 30:1, 10:1, 3:1, 1:1, 1:3 
and uninfected. 
24h after the first infection the supernatant and the 
cells were harvested with PBS+ 2mM EDTA. They were then 
spun down at 1300rpm fro 5min. After removing the 
supernatant the cells were resuspended in 100µl Annexin V 
binding Buffer (eBioscience). Then 5µl of Annexin V-FITC 
(eBioscience) or Annexin V-PE (eBioscience) was added and 
incubated for 10 minutes. An additional 200µl of Annexin V 
binding Buffer were added. Directly before FACS analyses 
5µl of propidium Iodide were added. 
 
7.8.2 Measuring the infection intensity with M2-AB 
 
To prove that macrophages were infected, we took 
them off after the live imaging experiment using PBS+2mM 
EDTA. Fresh macrophages were scraped off for uninfected 
control. They were then spun down at 1400rpm for 5min. 
Supernatant was sucked off and they were washed 2 times 
with 1ml FACS-Buffer. The mouse monoclonal directed to 
Influenza A Virus M2 Protein primary AB (Abcam), was 
incubated for 30 minutes on ice at a dilution of 1:200. The 
cells were then washed 2 times with 1ml FACS-Buffer. The 
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APC goat anti-mouse Ig secondary AB (Becton Dickins) was 
incubated for 30 minutes on ice in the dark, at a dilution of 
1:200. The cells were then washed one time with 1ml of 
FACS-Buffer. Then they were transferred to FACS-tubes in 
300µl of FACS-Buffer and analyzed via FACS Calibur (Becton 
Dickins). 
 
7.8.3 Phagocytic activity assay of macrophages 
 
Macrophages were seeded out between days 10-18. 
Single colour controls (SCC) were seeded out for 7aad 
(Becton Dickins) and unstained before further staining. 
For further staining with cell tracker green 
(Invitrogen) they were counted with Vi-Cell, Cell viability 
Analyzer (Beckman Coulter) to have a total of 1,1.107 
macrophages that were washed once in 10ml serum-free 
DMEM medium at 1400 rpm for 5 minutes. They were then 
taken up in 10ml DMEM with 0,8µl (0,8µM) cell tracker 
green and incubated for 30 minutes at 37oC with a rotation 
of 170. The cells were then centrifuged at 1400 rpm for 5 
minutes and taken up in complete medium to stop the 
staining. They were once more centrifuged and taken up in 
complete medium and then incubated for 30 minutes at 
37oC with a rotation of 170. Once more they were 
centrifuged at 1400 rpm for 5 minutes to be taken up in 1ml 
of complete macrophage medium. (64) They were counted 
1:10 with Vi-Cell, Cell viability Analyzer (Beckman Coulter) 
and taken up in enough medium to have 2.105 cells per well 
of a non-tissue culture treated 6 well plate (Becton Dickins). 
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2ml per well were seeded out onto 3x non-tissue culture 
treated 6-well plates and into the 3 empty wells of the 
already used 6-well plate (Figure 33). The top rows of the 
plates were infected at 1800 with a 2:1/1:3 
A/WSN/33(H1N1) strain of influenza A virus (IAV) while the 
lower ones stayed uninfected. 
 
A            B 
Influenza 
2:1/1:3 
Influenza 
2:1/1:3 
Influenza 
2:1/1:3 
 Stained 
influenza 
2:1/1:3 
Stained X 
Stained 
SCC 
X X X 
 Influenza 
2:1 
7aad SCC 
Unstained 
SCC 
 
 
Figure 33: Distribution of the macrophages for the 
phagocytic activity assay. A: Plated out 3 times for the 
combination with the LL/2 cells over 3 different time periods 
(1h/2h/4h). B: Cell death assay and SCC stains.  
 
The LL/2 cells were taken off by Trypsin-EDTA and 
counted with Vi-Cell, Cell viability Analyzer to have 5.105 
cells per well of a 6-well multidishes (Nunc). SCCs were 
seeded out for 7aad and unstained. For further staining a 
total of 4.107 LL/2 cells were taken and stained with PKH26 
for general cell membrane labelling (Sigma-Aldrich). The 
cells were once washed in 10ml serum-free DMEM medium 
with 1400 rpm for 5 minutes. The supernatant was carefully 
sucked off to leave no medium behind. 1ml Diluent C was 
used to resuspend the pellet thoroughly. Immediately 1ml of 
Diluent C with 8 µl (8µM) of PKH26 was added and left for 3 
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minutes while mildly inverting the tube. The reaction was 
stopped by adding an equal amount of FCS for 1 minute. 
Then an equal amount of complete medium was added and 
the cells were centrifuged with 1400 rpm for 10 minutes. 
The supernatant was sucked off and the pellet was 
transferred into a new tube for further washing. This was 
repeated 3 times. Cells were then taken up in complete 
medium. For the time points 4h, 2h and 1h we seeded 3.106 
cells into 9x 35mm tissue culture treated dish (Becton 
Dickins) in 4ml medium (Figure 34). Immediately after that 
the dishes for influenza A virus (IAV) were infected 5:1. 
Etoposide treated dishes were induced with 4µl (10mM 
concentration) of Etoposide. 
       4h    2h         1h 
  
 
        3.106 cells        3.106 cells    3.106 cells 
 
 
 
Figure 34: Setup with PKH26 labelled LL/2 cells. 3 dishes 
for each time point for analyses of A/WSN/33(H1N1) strain 
of influenza A virus (IAV) infected cells, Etoposide treated 
cells and untreated cells. 
 
On the next day the LL/2 cells and their supernatant 
were collected by taking them off with PBS/EDTA. They 
were washed once in macrophage medium with 1400 rpm at 
RT for 5min and then counted with Vi-Cell in a 1:10 dilution. 
Approximately 1.106 cells were added to the macrophages. 
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The first 2 wells received IAV infected cells, the second 2 
wells received Etoposide treated cells and the third 2 wells 
received the untreated samples. This procedure took place 
at 1000(4h) and was repeated at 1200(2h) and 1300(1h). The 
LL/2 cells from the 1h time point were then also used for 
cell death analyses and stained SCC. 
At 1400 the supernatant of the macrophages was 
sucked off and washed once with PBS. They were then 
taken off by incubating them with PBS/EDTA for 20min at 
37oC. The cells were then spun down at 4oC with 1400rpm 
for 5min. They were taken up in 200µl of FACS-Buffer and 
transferred into a 96well V-Bottom plate. They were washed 
once more with FACS-Buffer and then resuspended in 100µl 
FACS-Buffer. 5µl 7aad was added to all wells except for non 
7aad SCCs and kept at RT for 10 minutes. Cells were then 
transferred into small FACS-tubes with additional 200µl of 
FACS-Buffer and analysed via FACS Calibur (Becton 
Dickins). 
 
Inverted labeling: 
 
If PKH26 was used for macrophages, 4µl staining 
solution was used. 
If cell tracker green was used for LL/2 cells, 1.6µl 
staining solution was used. 
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8 Figure overview 
 
Figure 1: Structure of an IAV showing its various proteins. 
Image copyright by Dr. Markus Eickmann, Institute for 
Virology, Marburg, Germany ........................................... 9 
 
Figure 2: Shows the route of infection from an influenza 
Virus in an epithelial cell. Virus binds with hemagglutinin 
(HA) to the cell and gets taken up [1]. Release of the viral 
RNA and RNA polymerase into the cytoplasma from where it 
gets transported into the nucleus [2]. 
Transcription/replication of the RNA in the nucleus [3a/3b]. 
Translation of the mRNA in the cytoplasma [4]. Secretion of 
HA and neuroaminidase (NA) via Golgi apparatus to the cell 
surface [5b]. Viral proteins get transported back into the 
nucleus to bind viral RNA [5a]. Viral RNA and core proteins 
leave nucleus and enter a formed bulge [6]. The virus buds 
off from the cell with the help of neuroaminidase which cuts 
the sialic acid sugars on the cell surface [7] ................... 10 
 
Figure 3: Innate and adaptive immune responses against 
viruses. ..................................................................... 12 
 
Figure 4: Lung sections were stained by H&E and scored to 
look at epithelium damage. .......................................... 14 
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Figure 5: TNFα and its different inducable pathways leading 
either to antiapoptotic gene expression or to induction of 
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